Elisabeth Cronert-Bendell

Elisabeth Cronert-Bendell is a highly experienced professional with a diverse background in the healthcare industry, specializing in corporate, marketing, and competitive strategy.

With a double experience in both strategy consulting for Pharma/Biotech/Medical Device companies and operations such as Sales, Marketing, and Medical, Elisabeth brings a unique skill set to the table.

Her specialties include corporate, marketing, and competitive strategy, with a focus on lifecycle strategies, launch and market access action plans, as well as market segmentation and positioning.

Her expertise spans across various markets including neurology, psychiatry, pediatrics, nutrition, oncology, and vaccines.

Elisabeth Cronert-Bendell pursued her education at esteemed institutions, studying for an MBA at INSEAD and completing her MD with a specialty in Neurology at Université Paris-Est Créteil (UPEC).

She holds key positions in reputable organizations, currently serving as Head Of Strategy at Rhythm Pharmaceuticals after previously holding the position of Head of International Strategy at Rhythm Pharmaceuticals Inc.

Prior to her current roles, she has held significant positions such as Head of CNS Franchise at Kyowa Kirin International, Head of Strategy for Rare Diseases & Multiple Sclerosis / Neurology at Sanofi, Head of New Products Planning at Sanofi-Genzyme, and various other strategic and leadership roles at Sanofi Genzyme.

Before her tenure at Sanofi Genzyme, Elisabeth Cronert-Bendell served as the Marketing Director for Multiple Sclerosis (MS) at Sanofi Genzyme and the Sales and Marketing Director for Nephrology at Genzyme, a Sanofi Company, among other roles focusing on renal, cardiovascular, and other diseases.

Her career also includes consulting roles at Monitor Group and ISO Healthcare Consulting, as well as international project management at Servier and medical management at SODILAC.

With her wealth of experience and knowledge in the healthcare industry, Elisabeth Cronert-Bendell continues to make significant contributions and drive strategic initiatives in her field.